These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28157102)

  • 1. A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.
    Castellano CA; Paquet N; Dionne IJ; Imbeault H; Langlois F; Croteau E; Tremblay S; Fortier M; Matte JJ; Lacombe G; Fülöp T; Bocti C; Cunnane SC
    J Alzheimers Dis; 2017; 56(4):1459-1468. PubMed ID: 28157102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
    J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
    Croteau E; Castellano CA; Richard MA; Fortier M; Nugent S; Lepage M; Duchesne S; Whittingstall K; Turcotte ÉE; Bocti C; Fülöp T; Cunnane SC
    J Alzheimers Dis; 2018; 64(2):551-561. PubMed ID: 29914035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
    Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
    Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain glucose and acetoacetate metabolism: a comparison of young and older adults.
    Nugent S; Tremblay S; Chen KW; Ayutyanont N; Roontiva A; Castellano CA; Fortier M; Roy M; Courchesne-Loyer A; Bocti C; Lepage M; Turcotte E; Fulop T; Reiman EM; Cunnane SC
    Neurobiol Aging; 2014 Jun; 35(6):1386-95. PubMed ID: 24388785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Aerobic Training on Cognition and Brain Glucose Metabolism in Subjects with Mild Cognitive Impairment.
    Porto FH; Coutinho AM; Pinto AL; Gualano B; Duran FL; Prando S; Ono CR; Spíndola L; de Oliveira MO; do Vale PH; Nitrini R; Buchpiguel CA; Brucki SM
    J Alzheimers Dis; 2015; 46(3):747-60. PubMed ID: 25835427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment.
    Fortier M; Castellano CA; Croteau E; Langlois F; Bocti C; St-Pierre V; Vandenberghe C; Bernier M; Roy M; Descoteaux M; Whittingstall K; Lepage M; Turcotte ÉE; Fulop T; Cunnane SC
    Alzheimers Dement; 2019 May; 15(5):625-634. PubMed ID: 31027873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
    Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.
    Park S; Pyo S; Shin SA; Lee JY; Kim YK; Park HJ; Youn JH; Park SW; Lee JY
    Psychiatry Res Neuroimaging; 2018 Oct; 280():30-38. PubMed ID: 30145383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and brain imaging measures of Alzheimer's disease.
    Cutler NR
    Neurobiol Aging; 1988; 9(1):90-2. PubMed ID: 3260013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study.
    Courchesne-Loyer A; Croteau E; Castellano CA; St-Pierre V; Hennebelle M; Cunnane SC
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2485-2493. PubMed ID: 27629100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
    Bokde AL; Teipel SJ; Drzezga A; Thissen J; Bartenstein P; Dong W; Leinsinger G; Born C; Schwaiger M; Moeller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2005; 20(6):352-7. PubMed ID: 16192725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
    Tzimopoulou S; Cunningham VJ; Nichols TE; Searle G; Bird NP; Mistry P; Dixon IJ; Hallett WA; Whitcher B; Brown AP; Zvartau-Hind M; Lotay N; Lai RY; Castiglia M; Jeter B; Matthews JC; Chen K; Bandy D; Reiman EM; Gold M; Rabiner EA; Matthews PM
    J Alzheimers Dis; 2010; 22(4):1241-56. PubMed ID: 20930300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.
    Tauber C; Beaufils E; Hommet C; Ribeiro MJ; Vercouillie J; Vierron E; Mondon K; Cottier JP; Gissot V; Guilloteau D; Camus V
    J Alzheimers Dis; 2013; 36(2):311-20. PubMed ID: 23609763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.